Medical Mycology

Papers
(The median citation count of Medical Mycology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort36
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study29
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India27
P196 A rare presentation of subcutaneous Entomophthoramycosis27
P361 Demystifying the NIH grant application process for international investigators26
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis26
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain25
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis24
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management22
S1.3c Diversity and hybridization in Malassezia furfur21
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?20
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival20
S5.1b Antifungal r esistance20
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis19
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina19
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants19
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis18
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa16
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex15
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?15
OUP accepted manuscript14
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives14
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study14
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study14
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India14
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo14
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans13
A 40-Year Antifungal Susceptibility Surveillance of Talaromyces marneffei (1984–2024) at a Tertiary Hospital in Guangxi, China12
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil12
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis12
S10.4c Successful treatment of mucormycosis in hematological diseases12
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study12
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole12
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India12
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida11
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients11
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach11
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan11
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies10
S2.2a African histoplasmosis10
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report10
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective10
P192 Investigating the link between pleomorphism and virulence in Cryptococcus10
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China10
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia10
P355 Pitfalls in medical mycology in India9
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity9
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia9
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance9
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum9
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence9
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam9
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger9
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation9
P348 tRNA modifications in Candida virulence9
Antifungal efficacy of natural antiseptic products against Candida auris9
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina8
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon8
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia8
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis8
P303 An unusual case of isolated gluteal abscess8
P291 Aspergillosis: another force to reckon with during COVID-19 times8
Whole genome characterization of Trichophyton indotineae isolated in Singapore8
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study8
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis8
P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.8
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient8
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis8
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases8
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis8
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet8
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration8
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute8
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia7
Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel7
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan7
S9.5c Malassezia-host interactions and the Il-23/17 axis7
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease7
Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia7
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)7
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study7
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares7
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient7
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples7
Opaque cell-specific proteome ofCandida albicansATCC 102317
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma7
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation7
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?7
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality7
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals7
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy6
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India6
Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease6
A practical approach to investigating nosocomial acquisition of Aspergillus6
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility6
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples6
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies6
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils6
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study6
Risk factors for COVID-19 associated mucormycosis in India: A case control study6
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina6
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne6
Thanks to Reviewers6
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies6
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production6
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India6
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain6
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis6
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China6
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples6
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections5
Molecular detection of Enterocytozoon bieneusi in bats from Portugal5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale5
Antifungal prescribing in neonates: Using national point prevalence survey data from Australia5
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates5
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density5
P223 First case of Candida auris candidemia in Manipur, Northeast India5
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India5
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology5
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits5
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family5
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States5
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study5
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach5
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis5
Value of qPCR in the screening strategy for Candida auris5
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India5
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations5
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach5
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -195
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study5
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains5
Biochemical characterization and analysis of gene expression of an α-mannosidase secreted by Paracoccidioides brasiliensis5
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study5
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire5
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital5
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India5
P502 Mycology lab of the future—slants to sequencing5
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations5
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets4
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis4
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review4
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units4
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus4
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis4
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia4
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program4
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient4
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries4
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling4
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India4
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria4
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India4
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections4
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens4
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 20224
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing4
P075 Initial results of an international effort in screening new agents against Candida auris4
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report4
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.4
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens4
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study4
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series4
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic4
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study4
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network4
Cryptococcosis in domestic and wild animals: A review4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei4
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study4
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India4
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India4
Investigation of invasive fungal infection in tuberculosis/hiv coinfected patients4
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea3
P213 Lasiodiplodia theobromae: an emerging human pathogen3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)3
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens3
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study3
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina3
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis3
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls3
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database3
Madurella mycetomatis grains within a eumycetoma lesion are clonal3
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India3
P268 Laryngeal Mucormycosis: does mucor take the voice away?3
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis3
A Falciformispora senegalensis grain model in Galleria mellonella larvae3
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis3
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties3
A systematic review on distribution and antifungal resistance pattern ofCandidaspecies in the Indian population3
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility3
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis3
P162 Parinaud's Oculoglandular Syndrome as an atypical manifestation of sporotrichosis in Brazil3
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization3
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest3
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics3
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis3
Fungal yield from sterile specimens3
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens3
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study3
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection2
P242 Autochthonous cases of Madura foot from Jodhpur, Western Rajasthan, India2
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis2
Correction to: Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List2
P054 Two effects of curcumin to Candida albicans2
Geraniol inhibits both planktonic cells and biofilms of the Candida parapsilosis species complex: Highlight for the improved efficacy of amphotericin B, caspofungin and fluconazole plus Geranio2
S4.3b Candida glabrata-host interactions2
Molecular detection and species identification of dermatophytes by SYBR-Green real-time PCR in-house methodology using hair samples obtained from dogs and cats2
P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method2
The need for fast and accurate detection of dermatomycosis2
Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study2
Deubiquitination module is critical for oxidative stress response and biofilm formation in Candida glabrata2
The qualitative accuracy of clinical dermatophytes via matrix-assisted laser desorption ionization-time of flight mass spectrometry: A meta-analysis2
P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia2
P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same2
Detection of pan-azole resistant Aspergillus fumigatus in horticulture and a composting facility in Belgium2
P176 Basidiobolus meristosporus — anew species on the block!2
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris2
Histoplasmaantigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance2
S7.3d Environmental surveillance of Aspergillus fumigatus in Dutch agricultural crops2
Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis2
Association of adverse effects with high serum posaconazole concentrations2
P204 Secondary organizing pneumonia caused by Aspergillus flavus in immunocompromised patients2
High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency 2
Detection of Blastomyces gilchristii via metagenomic sequencing in outbreak-associated soils2
P231 The first case of neonatal fungemia caused by Aureobasidium melanogenum2
P151 Molecular epidemiology of environmental strains of Cryptococcus isolated from Varanasi, Uttar Pradesh, India2
Comparing the phenotypic, genotypic, and proteomic identification of Trichosporon species: A globally emerging yeast of medical importance2
Molecular epidemiology of seborrheic dermatitis/dandruff associated Malassezia species from northern India2
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature2
Invasive aspergillosis caused by cryptic species in transplant recipients: A review2
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa2
Comparison of coccidioidal complement fixation and quantitative immunodiffusion serology at a reference laboratory2
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India2
P367 Candida sepsis in neonates a neglected pathogen: study from neonatal intensive care unit tertiary care hospital2
P029 Synergic effect of deferoxamine combined with fluconazole against fluconazole-resistant Candida Spp. through inhibited Cek1 MAPK signaling pathway2
P098 Human protothecosis: Acase report in Northeastern Brazil2
Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis2
Invasive mold infection of the gastrointestinal tract: A case series of 22 immunocompromised patients from a single academic center2
0.12407517433167